METHOD OF TREATING PEMPHIGUS VULGARIS Russian patent published in 2014 - IPC A61K31/196 A61K31/573 A61P17/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, specifically dermatology, and can be used for treating patients with pemphigus vulgaris. That is ensured by prescribing prednisolone in a dose of 1 mg/kg/day for 7 days. On the 7^th day, Metoject is administered subcutaneously in a dose of 7.5 mg once a day for 3-4 weeks. On the following day of the above administration, the dose of prednisolone is reduced by 1/3, after the following injections, the dose of prednisolone is reduced by 5-10 mg after each following injection.

EFFECT: invention enables providing higher clinical effectiveness in the patients with pemphigus vulgaris with a lower risk of complications.

2 ex, 2 tbl